DOP38 A vedolizumab specific four-gene colonic signature accurately predicting future endoscopic remission in patients with inflammatory bowel disease

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: B Verstockt, S Verstockt, P Sudahakar, J Dehairs, H Blevi, G Van Assche, S Vermeire, M Ferrante

Journal title: Journal of Crohn's and Colitis

Journal number: 13/Supplement_1

Journal publisher: Elsevier Science

Published year: 2019

Published pages: S048-S048

ISSN: 1873-9946